PhD ceremony Ms. P.A. Erba: Imaging cardio-vascular infection
|When:||Mo 25-11-2013 at 09:00|
|Where:||Academiegebouw, Broerstraat 5, Groningen|
PhD ceremony: Ms. P.A. Erba
Dissertation: Imaging cardio-vascular infection
Promotor(s): prof. A. Signore, prof. G. Mariani, prof. R.A.J.O. Dierckx
Faculty: Medical Sciences
The introduction of a hybrid system for combining functional and anatomical imaging gave the opportunity to expand our clinical experience with 99mTc-HMPAO radio labelled leukocytes scintigraphy in the field of infectious disease, by applying these technologies to new challenging clinical setting as in the presence of cardiovascular system infections. We applied 99mTc-HMPAO SPECT/CT hybrid imaging to patients with infectious endocarditis (IE), cardiovascular implanted electronic device (CIED) infections, or late and low-grade late vascular graft infections (VPI). In addition, we tried to establish how the use of standardized imaging acquisition protocols and new, bacterial specific, radiopharmaceuticals may improve the scintigraphic accuracy. Our results demonstrate that the use of 99mTc-HMPAO-WBC scintigraphy is beneficial in patients with a high clinical probability of IE, CIED and VPI infections with the following main clinical indications: i) the confirmation of diagnosis in doubtful circumstances, ii) defining the extent of device involvement, and iii) detecting associated complications and septic embolisms, thus impacting on treatment strategy . SPECT/CT combined technology is preferred to visualize infection by 99mTc-HMPAO-WBCs . Our findings support the use of 99m Tc-HMPAO-WBC scintigraphy also to monitor the response to antimicrobial treatment . From a methodological perspective, we demonstrated that the most accurate imaging acquisition protocol for 99mTc-HMPAO-WBC scintigraphy is scanning at 3-4h and at 20-24h after 99mTc-HMPAO-WBCs injection, corrected for isotope decay. Semi-quantitative analysis might be deserved to doubtful cases. In view of the research on new radiopharmaceuticals to image infectious processes, our results suggest 68Ga-DOTA-Biotin as a suitable candidate for further clinical development.